These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23202613)

  • 41. Reperfusion in STEMI patients: still a role for cardioprotection?
    Ottani F; Limbruno U; Latini R; Misuraca L; Galvani M
    Minerva Cardioangiol; 2018 Aug; 66(4):452-463. PubMed ID: 29589674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC; Reiter RJ; Jimenez-Sosa A
    Contemp Clin Trials; 2007 Jul; 28(4):532-9. PubMed ID: 17123867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI.
    Ndrepepa G
    Coron Artery Dis; 2015 Jun; 26(4):341-55. PubMed ID: 25715338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
    Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
    J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacology of mitochondrial permeability transition pore inhibitors.
    Naryzhnaya NV; Maslov LN; Oeltgen PR
    Drug Dev Res; 2019 Dec; 80(8):1013-1030. PubMed ID: 31823411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction).
    Thiele H; Eitel I; Meinberg C; Desch S; Leuschner A; Pfeiffer D; Hartmann A; Lotze U; Strauss W; Schuler G;
    JACC Cardiovasc Interv; 2011 Jun; 4(6):605-14. PubMed ID: 21700245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Remote Ischemic Perconditioning to Reduce Reperfusion Injury During Acute ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis.
    McLeod SL; Iansavichene A; Cheskes S
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Adlam D; Zarebinski M; Uren NG; Ptaszynski P; Oldroyd KG; Munir S; Zaman A; Contractor H; Kiss RG; Édes I; Szachniewicz J; Nagy GG; Garcia MJ; Tomcsanyi J; Irving J; Sharp ASP; Musialek P; Lupkovics G; Shirodaria C; Selvanayagam JB; Quinn P; Ng L; Roth M; Insko MA; Haber B; Hill S; Siegel L; Tulloch S; Channon KM
    Int J Cardiol; 2022 Jan; 347():1-7. PubMed ID: 34774885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.
    Schaller S; Paradis S; Ngoh GA; Assaly R; Buisson B; Drouot C; Ostuni MA; Lacapere JJ; Bassissi F; Bordet T; Berdeaux A; Jones SP; Morin D; Pruss RM
    J Pharmacol Exp Ther; 2010 Jun; 333(3):696-706. PubMed ID: 20215409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset.
    Stiermaier T; Eitel I; de Waha S; Pöss J; Fuernau G; Thiele H; Desch S
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1571-1579. PubMed ID: 28439734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sevoflurane in acute myocardial infarction: a pilot randomized study.
    Lavi S; Bainbridge D; D'Alfonso S; Diamantouros P; Syed J; Jablonsky G; Lavi R
    Am Heart J; 2014 Nov; 168(5):776-83. PubMed ID: 25440807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
    Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
    Hausenloy DJ; Botker HE; Engstrom T; Erlinge D; Heusch G; Ibanez B; Kloner RA; Ovize M; Yellon DM; Garcia-Dorado D
    Eur Heart J; 2017 Apr; 38(13):935-941. PubMed ID: 27118196
    [No Abstract]   [Full Text] [Related]  

  • 57. Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study.
    Montalescot G; Lassen JF; Hamm CW; Lapostolle F; Silvain J; ten Berg JM; Cantor WJ; Goodman SG; Licour M; Tsatsaris A; van't Hof AW
    Am Heart J; 2013 Apr; 165(4):515-22. PubMed ID: 23537967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.
    Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr AC; Näsman P;
    Eur J Clin Pharmacol; 2003 May; 59(1):1-9. PubMed ID: 12743668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of postconditioning with lactate-enriched blood on in-hospital outcomes of patients with ST-segment elevation myocardial infarction.
    Koyama T; Munakata M; Akima T; Kageyama T; Shibata M; Moritani K; Kanki H; Ishikawa S; Mitamura H
    Int J Cardiol; 2016 Oct; 220():146-8. PubMed ID: 27379916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.